nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCB1—lung cancer	0.239	1	CbGaD
Levetiracetam—ABCC2—Paclitaxel—lung cancer	0.0465	0.0902	CbGbCtD
Levetiracetam—ABCC2—Irinotecan—lung cancer	0.0459	0.089	CbGbCtD
Levetiracetam—ABCC2—Vinblastine—lung cancer	0.0408	0.0791	CbGbCtD
Levetiracetam—ABCC2—Cisplatin—lung cancer	0.0374	0.0725	CbGbCtD
Levetiracetam—ABCC2—Etoposide—lung cancer	0.0368	0.0712	CbGbCtD
Levetiracetam—ABCC2—Docetaxel—lung cancer	0.0336	0.0652	CbGbCtD
Levetiracetam—ABCB1—Topotecan—lung cancer	0.0306	0.0594	CbGbCtD
Levetiracetam—ABCB1—Gefitinib—lung cancer	0.028	0.0543	CbGbCtD
Levetiracetam—ABCC2—Doxorubicin—lung cancer	0.0251	0.0486	CbGbCtD
Levetiracetam—ABCC2—Methotrexate—lung cancer	0.0243	0.0471	CbGbCtD
Levetiracetam—ABCB1—Vinorelbine—lung cancer	0.0216	0.0418	CbGbCtD
Levetiracetam—ABCB1—Crizotinib—lung cancer	0.0172	0.0333	CbGbCtD
Levetiracetam—ABCB1—Gemcitabine—lung cancer	0.0168	0.0325	CbGbCtD
Levetiracetam—ABCB1—Erlotinib—lung cancer	0.0166	0.0321	CbGbCtD
Levetiracetam—ABCB1—Paclitaxel—lung cancer	0.0152	0.0294	CbGbCtD
Levetiracetam—ABCB1—Irinotecan—lung cancer	0.015	0.029	CbGbCtD
Levetiracetam—ABCB1—Vinblastine—lung cancer	0.0133	0.0258	CbGbCtD
Levetiracetam—ABCB1—Cisplatin—lung cancer	0.0122	0.0236	CbGbCtD
Levetiracetam—ABCB1—Etoposide—lung cancer	0.012	0.0232	CbGbCtD
Levetiracetam—ABCB1—Docetaxel—lung cancer	0.011	0.0213	CbGbCtD
Levetiracetam—ABCB1—Doxorubicin—lung cancer	0.00817	0.0158	CbGbCtD
Levetiracetam—ABCB1—Methotrexate—lung cancer	0.00792	0.0153	CbGbCtD
Levetiracetam—SV2A—bronchus—lung cancer	0.00339	0.24	CbGeAlD
Levetiracetam—CACNA1B—respiratory system—lung cancer	0.00285	0.201	CbGeAlD
Levetiracetam—SV2A—lung—lung cancer	0.00219	0.155	CbGeAlD
Levetiracetam—CACNA1B—lung—lung cancer	0.00151	0.107	CbGeAlD
Levetiracetam—SV2A—lymph node—lung cancer	0.0015	0.106	CbGeAlD
Levetiracetam—CACNA1B—lymph node—lung cancer	0.00103	0.0731	CbGeAlD
Levetiracetam—CACNA1B—Calcium Regulation in the Cardiac Cell—SFN—lung cancer	0.000694	0.0123	CbGpPWpGaD
Levetiracetam—ABCC2—ABC-family proteins mediated transport—ABCC3—lung cancer	0.000672	0.0119	CbGpPWpGaD
Levetiracetam—CACNA1B—Calcium Regulation in the Cardiac Cell—ADCY1—lung cancer	0.000656	0.0116	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.000644	0.0114	CbGpPWpGaD
Levetiracetam—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	0.000623	0.011	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—CHRNB4—lung cancer	0.000616	0.0109	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—CHRNA3—lung cancer	0.000609	0.0108	CbGpPWpGaD
Levetiracetam—ABCB1—Drug Induction of Bile Acid Pathway—ABCC3—lung cancer	0.000576	0.0102	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—GNG11—lung cancer	0.000576	0.0102	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—CHRNA5—lung cancer	0.000573	0.0101	CbGpPWpGaD
Levetiracetam—ABCC2—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000566	0.01	CbGpPWpGaD
Levetiracetam—ABCC2—Irinotecan Pathway—APC—lung cancer	0.000525	0.0093	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—ADCY1—lung cancer	0.000518	0.00917	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—CHRNA3—lung cancer	0.000467	0.00827	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000459	0.00812	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—GNG11—lung cancer	0.000441	0.00782	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—ADCY1—lung cancer	0.000397	0.00703	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—HMGB2—lung cancer	0.000383	0.00679	CbGpPWpGaD
Levetiracetam—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	0.000376	0.00666	CbGpPWpGaD
Levetiracetam—ABCB1—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.000364	0.00645	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000358	0.00634	CbGpPWpGaD
Levetiracetam—ABCB1—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.000347	0.00615	CbGpPWpGaD
Levetiracetam—ABCC2—ABC-family proteins mediated transport—ABCB1—lung cancer	0.000342	0.00606	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—PRDX1—lung cancer	0.00034	0.00603	CbGpPWpGaD
Levetiracetam—ABCC2—lymph node—lung cancer	0.000335	0.0237	CbGeAlD
Levetiracetam—ABCB1—respiratory system—lung cancer	0.000332	0.0234	CbGeAlD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.000331	0.00586	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PGAM1—lung cancer	0.000328	0.0058	CbGpPWpGaD
Levetiracetam—ABCB1—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000327	0.00578	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—GSTM2—lung cancer	0.00032	0.00567	CbGpPWpGaD
Levetiracetam—ABCB1—ABC-family proteins mediated transport—ABCC3—lung cancer	0.000316	0.0056	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SDC4—lung cancer	0.000306	0.00542	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.000303	0.00536	CbGpPWpGaD
Levetiracetam—ABCB1—epithelium—lung cancer	0.000277	0.0196	CbGeAlD
Levetiracetam—ABCC2—ABC-family proteins mediated transport—APOA1—lung cancer	0.00027	0.00478	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SKI—lung cancer	0.00027	0.00478	CbGpPWpGaD
Levetiracetam—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000266	0.00471	CbGpPWpGaD
Levetiracetam—SV2A—Disease—B4GALT5—lung cancer	0.000262	0.00464	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—GSTA3—lung cancer	0.000258	0.00457	CbGpPWpGaD
Levetiracetam—ABCB1—trachea—lung cancer	0.000245	0.0173	CbGeAlD
Levetiracetam—ABCC2—NRF2 pathway—KEAP1—lung cancer	0.000243	0.0043	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—GSTA4—lung cancer	0.000236	0.00418	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PXN—lung cancer	0.000234	0.00415	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—GSTA2—lung cancer	0.00023	0.00407	CbGpPWpGaD
Levetiracetam—SV2A—Disease—AKR1C1—lung cancer	0.00023	0.00406	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—NDRG1—lung cancer	0.000229	0.00405	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—MCL1—lung cancer	0.000229	0.00405	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—GSTA1—lung cancer	0.000222	0.00393	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—ABCC3—lung cancer	0.000219	0.00388	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—BRAF—lung cancer	0.000219	0.00388	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000216	0.00382	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NPPA—lung cancer	0.000211	0.00374	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—UGT1A1—lung cancer	0.000206	0.00365	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PPIA—lung cancer	0.000206	0.00365	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ALDOA—lung cancer	0.000205	0.00362	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—lung cancer	0.000201	0.00357	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—NFE2L2—lung cancer	0.000196	0.00346	CbGpPWpGaD
Levetiracetam—ABCB1—bone marrow—lung cancer	0.000194	0.0137	CbGeAlD
Levetiracetam—SV2A—Disease—ADCY1—lung cancer	0.000193	0.00342	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ENO2—lung cancer	0.000189	0.00335	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PPP2R1B—lung cancer	0.000188	0.00333	CbGpPWpGaD
Levetiracetam—SV2A—Disease—SMARCA4—lung cancer	0.000188	0.00333	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—TGFA—lung cancer	0.000187	0.0033	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—MDM2—lung cancer	0.000184	0.00325	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—RAF1—lung cancer	0.000183	0.00324	CbGpPWpGaD
Levetiracetam—ABCB1—lung—lung cancer	0.000176	0.0124	CbGeAlD
Levetiracetam—SV2A—Disease—ENO1—lung cancer	0.000172	0.00305	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—lung cancer	0.00017	0.00302	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—GCLC—lung cancer	0.000168	0.00298	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—CYP2A6—lung cancer	0.000168	0.00298	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—ALDOA—lung cancer	0.000168	0.00298	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—BRAF—lung cancer	0.000168	0.00297	CbGpPWpGaD
Levetiracetam—SV2A—Disease—APP—lung cancer	0.00016	0.00283	CbGpPWpGaD
Levetiracetam—SV2A—Disease—FGF9—lung cancer	0.000159	0.00281	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—ABCG2—lung cancer	0.000159	0.00281	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000155	0.00274	CbGpPWpGaD
Levetiracetam—SV2A—Disease—JUNB—lung cancer	0.000152	0.00268	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—TF—lung cancer	0.000148	0.00261	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—ENO1—lung cancer	0.000141	0.0025	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—NQO1—lung cancer	0.000141	0.0025	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—MDM2—lung cancer	0.000141	0.00249	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—RAF1—lung cancer	0.00014	0.00248	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—lung cancer	0.000138	0.00245	CbGpPWpGaD
Levetiracetam—SV2A—Disease—FOXO3—lung cancer	0.000133	0.00235	CbGpPWpGaD
Levetiracetam—ABCB1—ABC-family proteins mediated transport—APOA1—lung cancer	0.000127	0.00225	CbGpPWpGaD
Levetiracetam—ABCB1—lymph node—lung cancer	0.00012	0.00851	CbGeAlD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—lung cancer	0.000118	0.00209	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—GSTP1—lung cancer	0.000118	0.00209	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HES1—lung cancer	0.000118	0.00208	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000117	0.00208	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ERCC2—lung cancer	0.00011	0.00195	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—GSTM1—lung cancer	0.000108	0.00192	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ERBB3—lung cancer	0.000108	0.00191	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—RHEB—lung cancer	0.000103	0.00183	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TERT—lung cancer	0.000103	0.00183	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—HRAS—lung cancer	0.000101	0.00178	CbGpPWpGaD
Levetiracetam—SV2A—Disease—FGFR1—lung cancer	0.0001	0.00177	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HIF1A—lung cancer	9.86e-05	0.00175	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—lung cancer	9.78e-05	0.00173	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—lung cancer	9.78e-05	0.00173	CbGpPWpGaD
Levetiracetam—SV2A—Disease—APOA1—lung cancer	9.52e-05	0.00169	CbGpPWpGaD
Levetiracetam—Drowsiness—Methotrexate—lung cancer	9.49e-05	0.000543	CcSEcCtD
Levetiracetam—Infestation NOS—Methotrexate—lung cancer	9.49e-05	0.000543	CcSEcCtD
Levetiracetam—Depression—Methotrexate—lung cancer	9.46e-05	0.000541	CcSEcCtD
Levetiracetam—Anorexia—Paclitaxel—lung cancer	9.44e-05	0.00054	CcSEcCtD
Levetiracetam—Pain—Cisplatin—lung cancer	9.43e-05	0.000539	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Methotrexate—lung cancer	9.41e-05	0.000538	CcSEcCtD
Levetiracetam—Muscular weakness—Doxorubicin—lung cancer	9.4e-05	0.000538	CcSEcCtD
Levetiracetam—Vomiting—Vinorelbine—lung cancer	9.36e-05	0.000535	CcSEcCtD
Levetiracetam—Body temperature increased—Gemcitabine—lung cancer	9.35e-05	0.000535	CcSEcCtD
Levetiracetam—Rash—Vinorelbine—lung cancer	9.28e-05	0.000531	CcSEcCtD
Levetiracetam—Dermatitis—Vinorelbine—lung cancer	9.28e-05	0.000531	CcSEcCtD
Levetiracetam—Stomatitis—Methotrexate—lung cancer	9.25e-05	0.000529	CcSEcCtD
Levetiracetam—Headache—Vinorelbine—lung cancer	9.23e-05	0.000528	CcSEcCtD
Levetiracetam—Conjunctivitis—Methotrexate—lung cancer	9.22e-05	0.000527	CcSEcCtD
Levetiracetam—Asthma—Doxorubicin—lung cancer	9.21e-05	0.000527	CcSEcCtD
Levetiracetam—Influenza—Doxorubicin—lung cancer	9.21e-05	0.000527	CcSEcCtD
Levetiracetam—Leukopenia—Docetaxel—lung cancer	9.21e-05	0.000527	CcSEcCtD
Levetiracetam—Eosinophilia—Doxorubicin—lung cancer	9.12e-05	0.000522	CcSEcCtD
Levetiracetam—Feeling abnormal—Cisplatin—lung cancer	9.09e-05	0.00052	CcSEcCtD
Levetiracetam—Paraesthesia—Etoposide—lung cancer	9.07e-05	0.000519	CcSEcCtD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—lung cancer	9.06e-05	0.0016	CbGpPWpGaD
Levetiracetam—Pancreatitis—Doxorubicin—lung cancer	9.03e-05	0.000517	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Paclitaxel—lung cancer	9.02e-05	0.000516	CcSEcCtD
Levetiracetam—Somnolence—Etoposide—lung cancer	8.98e-05	0.000514	CcSEcCtD
Levetiracetam—Cough—Docetaxel—lung cancer	8.98e-05	0.000513	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Methotrexate—lung cancer	8.97e-05	0.000513	CcSEcCtD
Levetiracetam—Insomnia—Paclitaxel—lung cancer	8.96e-05	0.000512	CcSEcCtD
Levetiracetam—Epistaxis—Methotrexate—lung cancer	8.95e-05	0.000512	CcSEcCtD
Levetiracetam—Hypersensitivity—Irinotecan—lung cancer	8.95e-05	0.000512	CcSEcCtD
Levetiracetam—Convulsion—Docetaxel—lung cancer	8.91e-05	0.00051	CcSEcCtD
Levetiracetam—Paraesthesia—Paclitaxel—lung cancer	8.89e-05	0.000509	CcSEcCtD
Levetiracetam—Bronchitis—Doxorubicin—lung cancer	8.86e-05	0.000507	CcSEcCtD
Levetiracetam—Agranulocytosis—Methotrexate—lung cancer	8.85e-05	0.000506	CcSEcCtD
Levetiracetam—Somnolence—Paclitaxel—lung cancer	8.81e-05	0.000504	CcSEcCtD
Levetiracetam—Decreased appetite—Etoposide—lung cancer	8.78e-05	0.000502	CcSEcCtD
Levetiracetam—Chest pain—Docetaxel—lung cancer	8.76e-05	0.000501	CcSEcCtD
Levetiracetam—Myalgia—Docetaxel—lung cancer	8.76e-05	0.000501	CcSEcCtD
Levetiracetam—Arthralgia—Docetaxel—lung cancer	8.76e-05	0.000501	CcSEcCtD
Levetiracetam—Pancytopenia—Doxorubicin—lung cancer	8.75e-05	0.0005	CcSEcCtD
Levetiracetam—Nausea—Vinorelbine—lung cancer	8.75e-05	0.0005	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Etoposide—lung cancer	8.72e-05	0.000499	CcSEcCtD
Levetiracetam—Dyspepsia—Paclitaxel—lung cancer	8.72e-05	0.000499	CcSEcCtD
Levetiracetam—Body temperature increased—Cisplatin—lung cancer	8.72e-05	0.000499	CcSEcCtD
Levetiracetam—Asthenia—Irinotecan—lung cancer	8.71e-05	0.000498	CcSEcCtD
Levetiracetam—Fatigue—Etoposide—lung cancer	8.71e-05	0.000498	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	8.7e-05	0.000497	CcSEcCtD
Levetiracetam—SV2A—Disease—KIT—lung cancer	8.69e-05	0.00154	CbGpPWpGaD
Levetiracetam—SV2A—Disease—APC—lung cancer	8.69e-05	0.00154	CbGpPWpGaD
Levetiracetam—Pain—Etoposide—lung cancer	8.64e-05	0.000494	CcSEcCtD
Levetiracetam—Constipation—Etoposide—lung cancer	8.64e-05	0.000494	CcSEcCtD
Levetiracetam—Neutropenia—Doxorubicin—lung cancer	8.62e-05	0.000493	CcSEcCtD
Levetiracetam—Decreased appetite—Paclitaxel—lung cancer	8.61e-05	0.000492	CcSEcCtD
Levetiracetam—SV2A—Disease—EGF—lung cancer	8.59e-05	0.00152	CbGpPWpGaD
Levetiracetam—Upper respiratory tract infection—Doxorubicin—lung cancer	8.56e-05	0.00049	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Paclitaxel—lung cancer	8.55e-05	0.000489	CcSEcCtD
Levetiracetam—Fatigue—Paclitaxel—lung cancer	8.54e-05	0.000488	CcSEcCtD
Levetiracetam—Hepatitis—Methotrexate—lung cancer	8.52e-05	0.000487	CcSEcCtD
Levetiracetam—Asthenia—Gemcitabine—lung cancer	8.49e-05	0.000485	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—TERT—lung cancer	8.47e-05	0.0015	CbGpPWpGaD
Levetiracetam—Constipation—Paclitaxel—lung cancer	8.47e-05	0.000484	CcSEcCtD
Levetiracetam—Pain—Paclitaxel—lung cancer	8.47e-05	0.000484	CcSEcCtD
Levetiracetam—Confusional state—Docetaxel—lung cancer	8.47e-05	0.000484	CcSEcCtD
Levetiracetam—Pharyngitis—Methotrexate—lung cancer	8.45e-05	0.000483	CcSEcCtD
Levetiracetam—Weight increased—Doxorubicin—lung cancer	8.39e-05	0.00048	CcSEcCtD
Levetiracetam—Pruritus—Gemcitabine—lung cancer	8.37e-05	0.000479	CcSEcCtD
Levetiracetam—Infection—Docetaxel—lung cancer	8.34e-05	0.000477	CcSEcCtD
Levetiracetam—Weight decreased—Doxorubicin—lung cancer	8.34e-05	0.000477	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—IL10—lung cancer	8.33e-05	0.00147	CbGpPWpGaD
Levetiracetam—Feeling abnormal—Etoposide—lung cancer	8.32e-05	0.000476	CcSEcCtD
Levetiracetam—Diarrhoea—Irinotecan—lung cancer	8.31e-05	0.000475	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Etoposide—lung cancer	8.26e-05	0.000472	CcSEcCtD
Levetiracetam—Nervous system disorder—Docetaxel—lung cancer	8.23e-05	0.000471	CcSEcCtD
Levetiracetam—Thrombocytopenia—Docetaxel—lung cancer	8.22e-05	0.00047	CcSEcCtD
Levetiracetam—Drowsiness—Doxorubicin—lung cancer	8.22e-05	0.00047	CcSEcCtD
Levetiracetam—Infestation—Doxorubicin—lung cancer	8.22e-05	0.00047	CcSEcCtD
Levetiracetam—Infestation NOS—Doxorubicin—lung cancer	8.22e-05	0.00047	CcSEcCtD
Levetiracetam—SV2A—Disease—BRAF—lung cancer	8.17e-05	0.00145	CbGpPWpGaD
Levetiracetam—Feeling abnormal—Paclitaxel—lung cancer	8.16e-05	0.000467	CcSEcCtD
Levetiracetam—Skin disorder—Docetaxel—lung cancer	8.15e-05	0.000466	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Doxorubicin—lung cancer	8.14e-05	0.000466	CcSEcCtD
Levetiracetam—Hypersensitivity—Cisplatin—lung cancer	8.12e-05	0.000465	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—HIF1A—lung cancer	8.1e-05	0.00144	CbGpPWpGaD
Levetiracetam—Gastrointestinal pain—Paclitaxel—lung cancer	8.1e-05	0.000463	CcSEcCtD
Levetiracetam—Diarrhoea—Gemcitabine—lung cancer	8.09e-05	0.000463	CcSEcCtD
Levetiracetam—SV2A—Disease—IL6R—lung cancer	8.07e-05	0.00143	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CREBBP—lung cancer	8.06e-05	0.00143	CbGpPWpGaD
Levetiracetam—Erythema multiforme—Methotrexate—lung cancer	8.05e-05	0.000461	CcSEcCtD
Levetiracetam—Dizziness—Irinotecan—lung cancer	8.03e-05	0.000459	CcSEcCtD
Levetiracetam—Stomatitis—Doxorubicin—lung cancer	8.01e-05	0.000458	CcSEcCtD
Levetiracetam—Anorexia—Docetaxel—lung cancer	8e-05	0.000458	CcSEcCtD
Levetiracetam—Abdominal pain—Etoposide—lung cancer	7.99e-05	0.000457	CcSEcCtD
Levetiracetam—Body temperature increased—Etoposide—lung cancer	7.99e-05	0.000457	CcSEcCtD
Levetiracetam—Urinary tract infection—Doxorubicin—lung cancer	7.99e-05	0.000457	CcSEcCtD
Levetiracetam—Conjunctivitis—Doxorubicin—lung cancer	7.99e-05	0.000457	CcSEcCtD
Levetiracetam—Eye disorder—Methotrexate—lung cancer	7.96e-05	0.000455	CcSEcCtD
Levetiracetam—Asthenia—Cisplatin—lung cancer	7.91e-05	0.000452	CcSEcCtD
Levetiracetam—Body temperature increased—Paclitaxel—lung cancer	7.83e-05	0.000448	CcSEcCtD
Levetiracetam—Abdominal pain—Paclitaxel—lung cancer	7.83e-05	0.000448	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Doxorubicin—lung cancer	7.77e-05	0.000444	CcSEcCtD
Levetiracetam—Epistaxis—Doxorubicin—lung cancer	7.75e-05	0.000443	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—FASLG—lung cancer	7.74e-05	0.00137	CbGpPWpGaD
Levetiracetam—Vomiting—Irinotecan—lung cancer	7.72e-05	0.000442	CcSEcCtD
Levetiracetam—CACNA1B—Neuronal System—HRAS—lung cancer	7.72e-05	0.00137	CbGpPWpGaD
Levetiracetam—Sinusitis—Doxorubicin—lung cancer	7.71e-05	0.000441	CcSEcCtD
Levetiracetam—Immune system disorder—Methotrexate—lung cancer	7.69e-05	0.00044	CcSEcCtD
Levetiracetam—SV2A—Disease—MAP2K1—lung cancer	7.69e-05	0.00136	CbGpPWpGaD
Levetiracetam—Mediastinal disorder—Methotrexate—lung cancer	7.68e-05	0.000439	CcSEcCtD
Levetiracetam—Agranulocytosis—Doxorubicin—lung cancer	7.67e-05	0.000438	CcSEcCtD
Levetiracetam—Rash—Irinotecan—lung cancer	7.66e-05	0.000438	CcSEcCtD
Levetiracetam—Dermatitis—Irinotecan—lung cancer	7.65e-05	0.000438	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Docetaxel—lung cancer	7.65e-05	0.000437	CcSEcCtD
Levetiracetam—SV2A—Disease—PIK3CD—lung cancer	7.64e-05	0.00135	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—lung cancer	7.61e-05	0.00135	CbGpPWpGaD
Levetiracetam—Headache—Irinotecan—lung cancer	7.61e-05	0.000435	CcSEcCtD
Levetiracetam—Insomnia—Docetaxel—lung cancer	7.59e-05	0.000434	CcSEcCtD
Levetiracetam—Diarrhoea—Cisplatin—lung cancer	7.54e-05	0.000431	CcSEcCtD
Levetiracetam—Paraesthesia—Docetaxel—lung cancer	7.54e-05	0.000431	CcSEcCtD
Levetiracetam—Alopecia—Methotrexate—lung cancer	7.53e-05	0.00043	CcSEcCtD
Levetiracetam—Vomiting—Gemcitabine—lung cancer	7.52e-05	0.00043	CcSEcCtD
Levetiracetam—Somnolence—Docetaxel—lung cancer	7.46e-05	0.000427	CcSEcCtD
Levetiracetam—Mental disorder—Methotrexate—lung cancer	7.46e-05	0.000427	CcSEcCtD
Levetiracetam—Rash—Gemcitabine—lung cancer	7.46e-05	0.000427	CcSEcCtD
Levetiracetam—Dermatitis—Gemcitabine—lung cancer	7.45e-05	0.000426	CcSEcCtD
Levetiracetam—Hypersensitivity—Etoposide—lung cancer	7.44e-05	0.000426	CcSEcCtD
Levetiracetam—Malnutrition—Methotrexate—lung cancer	7.41e-05	0.000424	CcSEcCtD
Levetiracetam—Headache—Gemcitabine—lung cancer	7.41e-05	0.000424	CcSEcCtD
Levetiracetam—Rhinitis—Doxorubicin—lung cancer	7.39e-05	0.000423	CcSEcCtD
Levetiracetam—Dyspepsia—Docetaxel—lung cancer	7.39e-05	0.000423	CcSEcCtD
Levetiracetam—Hepatitis—Doxorubicin—lung cancer	7.37e-05	0.000422	CcSEcCtD
Levetiracetam—Pharyngitis—Doxorubicin—lung cancer	7.32e-05	0.000419	CcSEcCtD
Levetiracetam—Decreased appetite—Docetaxel—lung cancer	7.3e-05	0.000417	CcSEcCtD
Levetiracetam—Hypersensitivity—Paclitaxel—lung cancer	7.3e-05	0.000417	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC34A2—lung cancer	7.28e-05	0.00129	CbGpPWpGaD
Levetiracetam—Gastrointestinal disorder—Docetaxel—lung cancer	7.25e-05	0.000415	CcSEcCtD
Levetiracetam—Asthenia—Etoposide—lung cancer	7.25e-05	0.000415	CcSEcCtD
Levetiracetam—Connective tissue disorder—Doxorubicin—lung cancer	7.25e-05	0.000414	CcSEcCtD
Levetiracetam—Fatigue—Docetaxel—lung cancer	7.24e-05	0.000414	CcSEcCtD
Levetiracetam—Nausea—Irinotecan—lung cancer	7.21e-05	0.000413	CcSEcCtD
Levetiracetam—Constipation—Docetaxel—lung cancer	7.18e-05	0.000411	CcSEcCtD
Levetiracetam—Pain—Docetaxel—lung cancer	7.18e-05	0.000411	CcSEcCtD
Levetiracetam—Back pain—Methotrexate—lung cancer	7.17e-05	0.00041	CcSEcCtD
Levetiracetam—Pruritus—Etoposide—lung cancer	7.15e-05	0.000409	CcSEcCtD
Levetiracetam—Asthenia—Paclitaxel—lung cancer	7.11e-05	0.000406	CcSEcCtD
Levetiracetam—Nausea—Gemcitabine—lung cancer	7.03e-05	0.000402	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCC3—lung cancer	7.03e-05	0.00124	CbGpPWpGaD
Levetiracetam—Vomiting—Cisplatin—lung cancer	7.01e-05	0.000401	CcSEcCtD
Levetiracetam—Pruritus—Paclitaxel—lung cancer	7.01e-05	0.000401	CcSEcCtD
Levetiracetam—Vision blurred—Methotrexate—lung cancer	6.99e-05	0.0004	CcSEcCtD
Levetiracetam—Erythema multiforme—Doxorubicin—lung cancer	6.97e-05	0.000399	CcSEcCtD
Levetiracetam—Rash—Cisplatin—lung cancer	6.95e-05	0.000398	CcSEcCtD
Levetiracetam—Dermatitis—Cisplatin—lung cancer	6.95e-05	0.000397	CcSEcCtD
Levetiracetam—Feeling abnormal—Docetaxel—lung cancer	6.92e-05	0.000396	CcSEcCtD
Levetiracetam—Diarrhoea—Etoposide—lung cancer	6.91e-05	0.000395	CcSEcCtD
Levetiracetam—Eye disorder—Doxorubicin—lung cancer	6.89e-05	0.000394	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Docetaxel—lung cancer	6.87e-05	0.000393	CcSEcCtD
Levetiracetam—SV2A—Disease—MDM2—lung cancer	6.84e-05	0.00121	CbGpPWpGaD
Levetiracetam—SV2A—Disease—RAF1—lung cancer	6.82e-05	0.00121	CbGpPWpGaD
Levetiracetam—Diarrhoea—Paclitaxel—lung cancer	6.78e-05	0.000388	CcSEcCtD
Levetiracetam—SV2A—Disease—ERBB2—lung cancer	6.75e-05	0.00119	CbGpPWpGaD
Levetiracetam—Dizziness—Etoposide—lung cancer	6.68e-05	0.000382	CcSEcCtD
Levetiracetam—Immune system disorder—Doxorubicin—lung cancer	6.66e-05	0.000381	CcSEcCtD
Levetiracetam—Vertigo—Methotrexate—lung cancer	6.66e-05	0.000381	CcSEcCtD
Levetiracetam—SV2A—Disease—PIK3CB—lung cancer	6.66e-05	0.00118	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MTOR—lung cancer	6.66e-05	0.00118	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	6.65e-05	0.00118	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CD4—lung cancer	6.65e-05	0.00118	CbGpPWpGaD
Levetiracetam—Mediastinal disorder—Doxorubicin—lung cancer	6.65e-05	0.00038	CcSEcCtD
Levetiracetam—Abdominal pain—Docetaxel—lung cancer	6.64e-05	0.00038	CcSEcCtD
Levetiracetam—Body temperature increased—Docetaxel—lung cancer	6.64e-05	0.00038	CcSEcCtD
Levetiracetam—Leukopenia—Methotrexate—lung cancer	6.64e-05	0.00038	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—CREBBP—lung cancer	6.62e-05	0.00117	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PTGS2—lung cancer	6.6e-05	0.00117	CbGpPWpGaD
Levetiracetam—Dizziness—Paclitaxel—lung cancer	6.55e-05	0.000375	CcSEcCtD
Levetiracetam—Nausea—Cisplatin—lung cancer	6.55e-05	0.000375	CcSEcCtD
Levetiracetam—Alopecia—Doxorubicin—lung cancer	6.52e-05	0.000373	CcSEcCtD
Levetiracetam—Cough—Methotrexate—lung cancer	6.47e-05	0.00037	CcSEcCtD
Levetiracetam—Mental disorder—Doxorubicin—lung cancer	6.46e-05	0.00037	CcSEcCtD
Levetiracetam—Convulsion—Methotrexate—lung cancer	6.42e-05	0.000367	CcSEcCtD
Levetiracetam—Vomiting—Etoposide—lung cancer	6.42e-05	0.000367	CcSEcCtD
Levetiracetam—Malnutrition—Doxorubicin—lung cancer	6.42e-05	0.000367	CcSEcCtD
Levetiracetam—Rash—Etoposide—lung cancer	6.37e-05	0.000364	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—GNG11—lung cancer	6.37e-05	0.00113	CbGpPWpGaD
Levetiracetam—Dermatitis—Etoposide—lung cancer	6.36e-05	0.000364	CcSEcCtD
Levetiracetam—Headache—Etoposide—lung cancer	6.33e-05	0.000362	CcSEcCtD
Levetiracetam—Chest pain—Methotrexate—lung cancer	6.31e-05	0.000361	CcSEcCtD
Levetiracetam—Myalgia—Methotrexate—lung cancer	6.31e-05	0.000361	CcSEcCtD
Levetiracetam—Arthralgia—Methotrexate—lung cancer	6.31e-05	0.000361	CcSEcCtD
Levetiracetam—Tension—Doxorubicin—lung cancer	6.3e-05	0.00036	CcSEcCtD
Levetiracetam—Vomiting—Paclitaxel—lung cancer	6.3e-05	0.00036	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	6.27e-05	0.000359	CcSEcCtD
Levetiracetam—Rash—Paclitaxel—lung cancer	6.25e-05	0.000357	CcSEcCtD
Levetiracetam—Dermatitis—Paclitaxel—lung cancer	6.24e-05	0.000357	CcSEcCtD
Levetiracetam—Nervousness—Doxorubicin—lung cancer	6.24e-05	0.000357	CcSEcCtD
Levetiracetam—Back pain—Doxorubicin—lung cancer	6.21e-05	0.000355	CcSEcCtD
Levetiracetam—Headache—Paclitaxel—lung cancer	6.21e-05	0.000355	CcSEcCtD
Levetiracetam—Hypersensitivity—Docetaxel—lung cancer	6.19e-05	0.000354	CcSEcCtD
Levetiracetam—Confusional state—Methotrexate—lung cancer	6.1e-05	0.000349	CcSEcCtD
Levetiracetam—Vision blurred—Doxorubicin—lung cancer	6.05e-05	0.000346	CcSEcCtD
Levetiracetam—Asthenia—Docetaxel—lung cancer	6.02e-05	0.000344	CcSEcCtD
Levetiracetam—Infection—Methotrexate—lung cancer	6.01e-05	0.000344	CcSEcCtD
Levetiracetam—Nausea—Etoposide—lung cancer	6e-05	0.000343	CcSEcCtD
Levetiracetam—Pruritus—Docetaxel—lung cancer	5.94e-05	0.00034	CcSEcCtD
Levetiracetam—Nervous system disorder—Methotrexate—lung cancer	5.93e-05	0.000339	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	5.93e-05	0.00105	CbGpPWpGaD
Levetiracetam—Thrombocytopenia—Methotrexate—lung cancer	5.92e-05	0.000339	CcSEcCtD
Levetiracetam—Agitation—Doxorubicin—lung cancer	5.9e-05	0.000337	CcSEcCtD
Levetiracetam—Nausea—Paclitaxel—lung cancer	5.88e-05	0.000336	CcSEcCtD
Levetiracetam—Skin disorder—Methotrexate—lung cancer	5.88e-05	0.000336	CcSEcCtD
Levetiracetam—Vertigo—Doxorubicin—lung cancer	5.77e-05	0.00033	CcSEcCtD
Levetiracetam—Anorexia—Methotrexate—lung cancer	5.77e-05	0.00033	CcSEcCtD
Levetiracetam—SV2A—Disease—CDKN1A—lung cancer	5.77e-05	0.00102	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CASP8—lung cancer	5.76e-05	0.00102	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PTEN—lung cancer	5.75e-05	0.00102	CbGpPWpGaD
Levetiracetam—Leukopenia—Doxorubicin—lung cancer	5.75e-05	0.000329	CcSEcCtD
Levetiracetam—Diarrhoea—Docetaxel—lung cancer	5.74e-05	0.000329	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ADCY1—lung cancer	5.73e-05	0.00101	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCG2—lung cancer	5.73e-05	0.00101	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—APP—lung cancer	5.62e-05	0.000995	CbGpPWpGaD
Levetiracetam—Cough—Doxorubicin—lung cancer	5.6e-05	0.00032	CcSEcCtD
Levetiracetam—Convulsion—Doxorubicin—lung cancer	5.56e-05	0.000318	CcSEcCtD
Levetiracetam—Dizziness—Docetaxel—lung cancer	5.55e-05	0.000318	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC22A18—lung cancer	5.51e-05	0.000976	CbGpPWpGaD
Levetiracetam—Musculoskeletal discomfort—Methotrexate—lung cancer	5.51e-05	0.000315	CcSEcCtD
Levetiracetam—SV2A—Disease—EP300—lung cancer	5.49e-05	0.000972	CbGpPWpGaD
Levetiracetam—Insomnia—Methotrexate—lung cancer	5.47e-05	0.000313	CcSEcCtD
Levetiracetam—Arthralgia—Doxorubicin—lung cancer	5.47e-05	0.000313	CcSEcCtD
Levetiracetam—Chest pain—Doxorubicin—lung cancer	5.47e-05	0.000313	CcSEcCtD
Levetiracetam—Myalgia—Doxorubicin—lung cancer	5.47e-05	0.000313	CcSEcCtD
Levetiracetam—Anxiety—Doxorubicin—lung cancer	5.45e-05	0.000312	CcSEcCtD
Levetiracetam—Paraesthesia—Methotrexate—lung cancer	5.43e-05	0.000311	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.43e-05	0.00031	CcSEcCtD
Levetiracetam—Somnolence—Methotrexate—lung cancer	5.38e-05	0.000308	CcSEcCtD
Levetiracetam—Vomiting—Docetaxel—lung cancer	5.34e-05	0.000305	CcSEcCtD
Levetiracetam—SV2A—Disease—SRC—lung cancer	5.34e-05	0.000945	CbGpPWpGaD
Levetiracetam—Dyspepsia—Methotrexate—lung cancer	5.33e-05	0.000305	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—TF—lung cancer	5.32e-05	0.000943	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	5.32e-05	0.000942	CbGpPWpGaD
Levetiracetam—Rash—Docetaxel—lung cancer	5.29e-05	0.000303	CcSEcCtD
Levetiracetam—Dermatitis—Docetaxel—lung cancer	5.29e-05	0.000302	CcSEcCtD
Levetiracetam—Confusional state—Doxorubicin—lung cancer	5.28e-05	0.000302	CcSEcCtD
Levetiracetam—Decreased appetite—Methotrexate—lung cancer	5.26e-05	0.000301	CcSEcCtD
Levetiracetam—Headache—Docetaxel—lung cancer	5.26e-05	0.000301	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Methotrexate—lung cancer	5.22e-05	0.000299	CcSEcCtD
Levetiracetam—Fatigue—Methotrexate—lung cancer	5.22e-05	0.000298	CcSEcCtD
Levetiracetam—Infection—Doxorubicin—lung cancer	5.21e-05	0.000298	CcSEcCtD
Levetiracetam—Pain—Methotrexate—lung cancer	5.17e-05	0.000296	CcSEcCtD
Levetiracetam—SV2A—Disease—STAT3—lung cancer	5.15e-05	0.000911	CbGpPWpGaD
Levetiracetam—Nervous system disorder—Doxorubicin—lung cancer	5.14e-05	0.000294	CcSEcCtD
Levetiracetam—SV2A—Disease—NRAS—lung cancer	5.13e-05	0.000909	CbGpPWpGaD
Levetiracetam—Thrombocytopenia—Doxorubicin—lung cancer	5.13e-05	0.000293	CcSEcCtD
Levetiracetam—Skin disorder—Doxorubicin—lung cancer	5.09e-05	0.000291	CcSEcCtD
Levetiracetam—Anorexia—Doxorubicin—lung cancer	4.99e-05	0.000286	CcSEcCtD
Levetiracetam—Nausea—Docetaxel—lung cancer	4.99e-05	0.000285	CcSEcCtD
Levetiracetam—Feeling abnormal—Methotrexate—lung cancer	4.99e-05	0.000285	CcSEcCtD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—lung cancer	4.99e-05	0.000883	CbGpPWpGaD
Levetiracetam—Gastrointestinal pain—Methotrexate—lung cancer	4.95e-05	0.000283	CcSEcCtD
Levetiracetam—SV2A—Disease—MAPK3—lung cancer	4.92e-05	0.000871	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—JUN—lung cancer	4.89e-05	0.000865	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	4.83e-05	0.000856	CbGpPWpGaD
Levetiracetam—Body temperature increased—Methotrexate—lung cancer	4.78e-05	0.000274	CcSEcCtD
Levetiracetam—Abdominal pain—Methotrexate—lung cancer	4.78e-05	0.000274	CcSEcCtD
Levetiracetam—SV2A—Disease—MYC—lung cancer	4.78e-05	0.000847	CbGpPWpGaD
Levetiracetam—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.77e-05	0.000273	CcSEcCtD
Levetiracetam—Insomnia—Doxorubicin—lung cancer	4.74e-05	0.000271	CcSEcCtD
Levetiracetam—Paraesthesia—Doxorubicin—lung cancer	4.7e-05	0.000269	CcSEcCtD
Levetiracetam—SV2A—Disease—EGFR—lung cancer	4.68e-05	0.000828	CbGpPWpGaD
Levetiracetam—Somnolence—Doxorubicin—lung cancer	4.66e-05	0.000266	CcSEcCtD
Levetiracetam—Dyspepsia—Doxorubicin—lung cancer	4.61e-05	0.000264	CcSEcCtD
Levetiracetam—Decreased appetite—Doxorubicin—lung cancer	4.55e-05	0.00026	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—CXCL8—lung cancer	4.55e-05	0.000806	CbGpPWpGaD
Levetiracetam—Gastrointestinal disorder—Doxorubicin—lung cancer	4.52e-05	0.000259	CcSEcCtD
Levetiracetam—Fatigue—Doxorubicin—lung cancer	4.52e-05	0.000258	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—EP300—lung cancer	4.51e-05	0.000798	CbGpPWpGaD
Levetiracetam—Pain—Doxorubicin—lung cancer	4.48e-05	0.000256	CcSEcCtD
Levetiracetam—Constipation—Doxorubicin—lung cancer	4.48e-05	0.000256	CcSEcCtD
Levetiracetam—Hypersensitivity—Methotrexate—lung cancer	4.46e-05	0.000255	CcSEcCtD
Levetiracetam—SV2A—Disease—KRAS—lung cancer	4.42e-05	0.000782	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CASP3—lung cancer	4.36e-05	0.000772	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL2—lung cancer	4.35e-05	0.00077	CbGpPWpGaD
Levetiracetam—Asthenia—Methotrexate—lung cancer	4.34e-05	0.000248	CcSEcCtD
Levetiracetam—Feeling abnormal—Doxorubicin—lung cancer	4.32e-05	0.000247	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Doxorubicin—lung cancer	4.28e-05	0.000245	CcSEcCtD
Levetiracetam—Pruritus—Methotrexate—lung cancer	4.28e-05	0.000245	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—lung cancer	4.27e-05	0.000756	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	4.16e-05	0.000736	CbGpPWpGaD
Levetiracetam—Abdominal pain—Doxorubicin—lung cancer	4.14e-05	0.000237	CcSEcCtD
Levetiracetam—Body temperature increased—Doxorubicin—lung cancer	4.14e-05	0.000237	CcSEcCtD
Levetiracetam—Diarrhoea—Methotrexate—lung cancer	4.14e-05	0.000237	CcSEcCtD
Levetiracetam—SV2A—Disease—PIK3CA—lung cancer	4.06e-05	0.000719	CbGpPWpGaD
Levetiracetam—Dizziness—Methotrexate—lung cancer	4e-05	0.000229	CcSEcCtD
Levetiracetam—Hypersensitivity—Doxorubicin—lung cancer	3.86e-05	0.000221	CcSEcCtD
Levetiracetam—Vomiting—Methotrexate—lung cancer	3.85e-05	0.00022	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	3.82e-05	0.000676	CbGpPWpGaD
Levetiracetam—Rash—Methotrexate—lung cancer	3.82e-05	0.000218	CcSEcCtD
Levetiracetam—Dermatitis—Methotrexate—lung cancer	3.81e-05	0.000218	CcSEcCtD
Levetiracetam—Headache—Methotrexate—lung cancer	3.79e-05	0.000217	CcSEcCtD
Levetiracetam—Asthenia—Doxorubicin—lung cancer	3.76e-05	0.000215	CcSEcCtD
Levetiracetam—SV2A—Disease—HRAS—lung cancer	3.76e-05	0.000665	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—COL4A3BP—lung cancer	3.73e-05	0.00066	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AZIN2—lung cancer	3.73e-05	0.00066	CbGpPWpGaD
Levetiracetam—Pruritus—Doxorubicin—lung cancer	3.71e-05	0.000212	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—VEGFA—lung cancer	3.7e-05	0.000655	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—AVP—lung cancer	3.69e-05	0.000654	CbGpPWpGaD
Levetiracetam—SV2A—Disease—IL6—lung cancer	3.59e-05	0.000637	CbGpPWpGaD
Levetiracetam—Nausea—Methotrexate—lung cancer	3.59e-05	0.000206	CcSEcCtD
Levetiracetam—Diarrhoea—Doxorubicin—lung cancer	3.58e-05	0.000205	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCB1—lung cancer	3.57e-05	0.000633	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	3.52e-05	0.000623	CbGpPWpGaD
Levetiracetam—Dizziness—Doxorubicin—lung cancer	3.46e-05	0.000198	CcSEcCtD
Levetiracetam—Vomiting—Doxorubicin—lung cancer	3.33e-05	0.000191	CcSEcCtD
Levetiracetam—SV2A—Disease—AKT1—lung cancer	3.32e-05	0.000587	CbGpPWpGaD
Levetiracetam—Rash—Doxorubicin—lung cancer	3.3e-05	0.000189	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCC3—lung cancer	3.3e-05	0.000585	CbGpPWpGaD
Levetiracetam—Dermatitis—Doxorubicin—lung cancer	3.3e-05	0.000189	CcSEcCtD
Levetiracetam—Headache—Doxorubicin—lung cancer	3.28e-05	0.000188	CcSEcCtD
Levetiracetam—ABCB1—Metabolism—ATP5H—lung cancer	3.17e-05	0.000561	CbGpPWpGaD
Levetiracetam—Nausea—Doxorubicin—lung cancer	3.11e-05	0.000178	CcSEcCtD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	3.05e-05	0.00054	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	3.02e-05	0.000534	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	2.99e-05	0.00053	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	2.84e-05	0.000503	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	2.83e-05	0.000501	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PLBD1—lung cancer	2.82e-05	0.0005	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—APOA1—lung cancer	2.82e-05	0.0005	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	2.72e-05	0.000482	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	2.7e-05	0.000478	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	2.69e-05	0.000477	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	2.69e-05	0.000477	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HSD17B10—lung cancer	2.58e-05	0.000457	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	2.5e-05	0.000443	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	2.4e-05	0.000426	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CKB—lung cancer	2.4e-05	0.000425	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	2.39e-05	0.000424	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—CREBBP—lung cancer	2.39e-05	0.000423	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	2.37e-05	0.00042	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	2.32e-05	0.00041	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CNDP2—lung cancer	2.26e-05	0.0004	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTM2—lung cancer	2.26e-05	0.0004	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ALB—lung cancer	2.24e-05	0.000396	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MTMR3—lung cancer	2.2e-05	0.000389	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	2.15e-05	0.000381	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PGAM1—lung cancer	2.14e-05	0.000379	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	2.09e-05	0.000371	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	2.09e-05	0.00037	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP2A7—lung cancer	2.04e-05	0.000362	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	2.02e-05	0.000359	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—RAF1—lung cancer	2.02e-05	0.000358	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	2.02e-05	0.000358	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SDC4—lung cancer	2e-05	0.000354	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.93e-05	0.000341	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.87e-05	0.000332	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.82e-05	0.000323	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—RRM1—lung cancer	1.82e-05	0.000322	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTA3—lung cancer	1.82e-05	0.000322	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.74e-05	0.000307	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.73e-05	0.000306	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—B4GALT5—lung cancer	1.71e-05	0.000303	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.68e-05	0.000297	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTA4—lung cancer	1.66e-05	0.000295	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.64e-05	0.000291	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTA2—lung cancer	1.62e-05	0.000287	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTA1—lung cancer	1.56e-05	0.000277	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.55e-05	0.000275	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ABCC3—lung cancer	1.55e-05	0.000274	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AKR1C1—lung cancer	1.5e-05	0.000265	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—UGT1A1—lung cancer	1.45e-05	0.000258	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.43e-05	0.000252	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GNG11—lung cancer	1.4e-05	0.000248	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.38e-05	0.000244	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALDOA—lung cancer	1.34e-05	0.000237	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.33e-05	0.000235	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NCOA3—lung cancer	1.3e-05	0.00023	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ABCG2—lung cancer	1.26e-05	0.000223	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ADCY1—lung cancer	1.26e-05	0.000223	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HPGDS—lung cancer	1.24e-05	0.000219	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ENO2—lung cancer	1.24e-05	0.000219	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PPP2R1B—lung cancer	1.23e-05	0.000218	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTT1—lung cancer	1.2e-05	0.000212	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GCLC—lung cancer	1.19e-05	0.00021	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP2A6—lung cancer	1.19e-05	0.00021	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.16e-05	0.000206	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ENO1—lung cancer	1.12e-05	0.000199	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.12e-05	0.000199	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	1.05e-05	0.000186	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP2E1—lung cancer	1.01e-05	0.000179	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—NQO1—lung cancer	9.97e-06	0.000177	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	9.51e-06	0.000168	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—STK11—lung cancer	8.99e-06	0.000159	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTP1—lung cancer	8.32e-06	0.000147	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CAT—lung cancer	8.09e-06	0.000143	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—TYMS—lung cancer	7.73e-06	0.000137	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GSTM1—lung cancer	7.64e-06	0.000135	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP1A1—lung cancer	7.24e-06	0.000128	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ERCC2—lung cancer	7.18e-06	0.000127	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—APOA1—lung cancer	6.21e-06	0.00011	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CG—lung cancer	5.67e-06	0.0001	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—POMC—lung cancer	5.4e-06	9.56e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CREBBP—lung cancer	5.26e-06	9.32e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CD—lung cancer	4.99e-06	8.83e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALB—lung cancer	4.92e-06	8.72e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CB—lung cancer	4.35e-06	7.7e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTGS2—lung cancer	4.31e-06	7.63e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTEN—lung cancer	3.76e-06	6.65e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—EP300—lung cancer	3.58e-06	6.34e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CA—lung cancer	2.65e-06	4.69e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AKT1—lung cancer	2.17e-06	3.83e-05	CbGpPWpGaD
